Course:204A

Course Code: 204A

SPEAKER: Andrew Salama, DDS, MD

DATE: Wednesday, April 3rd – 8:30 am to 11:30 am

CREDIT HOURS: 3

Andrew Salama, DDS, MD
Dr. Salama obtained his DDS and MD degrees from the University of Maryland School of Dental Medicine and School of Medicine respectively. He completed his OMFS training at the University of Maryland in 2005, and joined the faculty at the University of Maryland Medical Center following the completion of a Fellowship in Oral and Maxillofacial Oncology and Reconstruction in 2007. His primary clinical interests include treatment of head and neck malignancies and tumors, microvascular reconstruction and surgical management of craniofacial trauma.

He has a commitment to teaching on many levels and is currently a professor and Chief of Oral and Maxillofacial Surgery at Northwell Health-Long Island Jewish Medicine Center. His current clinical research involves evaluating bone healing following reconstruction of the mandible with microvascular free tissue transfer and SEER based outcomes for head and neck cancer. He has published extensively in the peer-reviewed literature and has written several textbook chapters. He has traveled nationally and internationally to present abstracts and research.
in Roslyn, NY.

PART 1

Head and Cancer and HPV: An Update for Dental Providers

Objectives:

• Describe Pathophysiology of HPV and cancer
• Discuss demographics of HPV related cancers
• Outline know risk factors for HPV specific head and neck cancers
• Delineate non-HPV from HPV+ head and neck cancers
• Discuss evolving therapies for HPV related cancer

Outcomes –

The participants will be able to:

• To describe the etiology of HPV related cancer of the head and neck
• To review the differences between HPV+ and HPV- head and neck cancers
• To distinguish the difference between oral cavity and oropharyngeal cancers
• To Describe basic treatment strategies including de-escalation and de-intensification of treatment of HPV + head and neck cancers
• To identify the impact of dental providers on early detection of head and neck cancers

PART 2

An introduction to Medical Cannabis for Dentists

Objectives:

• Describe the difference between cannabis as drug versus a medicine
• Review the governance of controlled substances and the re-emergence of schedule I drugs as therapeutics.
• Discuss selectively targeting the endogenous cannabinoid receptor system
• Review evidence-based outcomes for cannabis use in a variety of conditions
• Introduce potential legal ramifications of treating patients under the influence of cannabis and cannabis based products

Outcomes –

The participants will be able to:

• Discuss the life cycle of cannabis use through history and it’s re-introduction to medicinal use
• Describe the basic effects of cannabinoid receptor activation
• Discuss the impact of terpenes as they relate to cannabis efficacy
• Recognize legitimate cannabis-based therapeutics